Compare · COCH vs SNN
COCH vs SNN
Side-by-side comparison of Envoy Medical Inc. (COCH) and Smith & Nephew SNATS Inc. (SNN): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both COCH and SNN operate in Industrial Specialties (Health Care), so they compete in similar markets.
- SNN is the larger of the two at $13.31B, about 279.2x COCH ($47.7M).
- Over the past year, COCH is down 54.8% and SNN is up 3.4% - SNN leads by 58.2 points.
- SNN has been more active in the news (13 items in the past 4 weeks vs 5 for COCH).
- SNN has more recent analyst coverage (23 ratings vs 2 for COCH).
- Company
- Envoy Medical Inc.
- Smith & Nephew SNATS Inc.
- Price
- $0.65+3.84%
- $31.09-0.73%
- Market cap
- $47.7M
- $13.31B
- 1M return
- +1.56%
- +6.84%
- 1Y return
- -54.83%
- +3.36%
- Industry
- Industrial Specialties
- Industrial Specialties
- Exchange
- NASDAQ
- NYSE
- IPO
- 2021
- News (4w)
- 5
- 13
- Recent ratings
- 2
- 23
Smith & Nephew SNATS Inc.
Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices worldwide. The company offers knee implant products for knee replacement procedures; hip implants for the reconstruction of hip joints; and trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures. It also provides sports medicine joint repair products for surgeons, including instruments, technologies, and implants necessary to perform minimally invasive surgery of the joints, such as the repair of soft tissue injuries and degenerative conditions of the knee, hip, and shoulder, as well as meniscal repair systems. In addition, the company offers arthroscopic enabling technologies comprising fluid management equipment for surgical access, high definition cameras, digital image capture, scopes, light sources, and monitors to assist with visualization inside the joints, radio frequency, electromechanical and mechanical tissue resection devices, and hand instruments for removing damaged tissue; and ear, nose, and throat solutions. Further, it provides advanced wound care products for the treatment and prevention of acute and chronic wounds, which comprise leg, diabetic and pressure ulcers, burns, and post-operative wounds; advanced wound bioactives, including biologics and other bioactive technologies for debridement and dermal repair/regeneration, as well as regenerative medicine products including skin, bone graft, and articular cartilage substitutes; and advanced wound devices, such as traditional and single-use negative pressure wound therapy, and hydrosurgery systems. It primarily serves the healthcare providers. The company was founded in 1856 and is headquartered in Watford, the United Kingdom.
Latest COCH
- Chief Executive Officer Lucas Brent T. was granted 32,856 shares, increasing direct ownership by 11% to 329,946 units (SEC Form 4)
- Envoy Medical to Present at Planet MicroCap Conference Las Vegas on June 16th-18th
- Envoy Medical Inc. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
- Envoy Medical Announces New Patents Expanding Intellectual Property Portfolio in Fully Implanted Hearing Technology
- Envoy Medical Inc. filed SEC Form 8-K: Leadership Update, Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits
- SEC Form SCHEDULE 13G filed by Envoy Medical Inc.
- SEC Form SCHEDULE 13G filed by Envoy Medical Inc.
- Amendment: SEC Form SCHEDULE 13G/A filed by Envoy Medical Inc.
- SEC Form 10-Q filed by Envoy Medical Inc.
- Envoy Medical Inc. filed SEC Form 8-K: Results of Operations and Financial Condition
Latest SNN
- A Fresh FDA Catalyst Is Putting Regenerative Wound Care in Focus
- Smith+Nephew announces first clinical cases with the next generation CORI◊XT Handheld Robotics Platform across knee and shoulder arthroplasty
- SEC Form 6-K filed by Smith & Nephew SNATS Inc.
- Smith & Nephew downgraded by Kepler
- SEC Form 6-K filed by Smith & Nephew SNATS Inc.
- SEC Form 6-K filed by Smith & Nephew SNATS Inc.
- Smith+Nephew launch next generation LEAF™ Patient Monitoring System – an innovative pressure injury prevention platform delivering proven clinical impact
- SEC Form 6-K filed by Smith & Nephew SNATS Inc.
- SEC Form 6-K filed by Smith & Nephew SNATS Inc.
- A Reno Biotech Just Rang the Nasdaq Bell — Here's Why the Whole Regenerative-Medicine Tape Is Worth Watching